Valeant SEC Probe

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) is facing an undisclosed SEC investigation, according to a report by Probes Reporter, an independent publisher of investment research that focuses on public company interactions with the SEC, Probes Reporter noted that it received a letter dated...